Explore more publications!

The Pennsylvania Post: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Pennsylvania Post.

Press releases published on December 15, 2025

KDG Recognized on the Clutch 1000 List for 2025
Jason Rhoads Receives Silver Award Honors for  NAHB’s ‘Sales & Marketing Professional of the Year’
HMP Global’s Symposium on Advanced Wound Care (SAWC) Announces 2026 Partnership with NPIAP
PECO Customers to Pay $20/Month More in 2026
Deborah Ann Mack Reintroduces the Art of Heirloom Fashion for the Holiday Season
Appluent Business Solutions Announces Official HubSpot Partnership, Expanding Hybrid CRM Capabilities for Customers
Crane Harbor Acquisition Corp. II Announces the Upsized Pricing of $300,000,000 Initial Public Offering
Cove Risk Services Data Breach Claims Investigated by Lynch Carpenter
Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
DEADLINE ALERT for FUN, TLX, LRN, PRMB: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions
Kessler Topaz Meltzer & Check, LLP - FLY Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Firefly Aerospace Inc. (FLY)
Rockrose Development Data Breach Claims Investigated by Lynch Carpenter
Camden National Bank Launches Free Youth Banking Platform to Teach the Value of Money
New Toll Brothers Luxury Home Community Coming Soon to Westminster, Colorado
Xanadu to receive up to $23M from new Canadian Quantum Champions Program
Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing
Important Notice to Long-Term Shareholders of Alexandria Real Estate Equities, Inc. (NYSE: ARE); Integer Holdings Corp. (NYSE: ITGR); StubHub Holdings, Inc. (NYSE: STUB) and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates…
CubeSmart Announces 1.9% Increase in Quarterly Common Dividend
Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Palvella Therapeutics Announces Positive Topline Results from Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations, a Serious, Rare Genetic Disease with No…

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions